Comparison of cefprozil and cefaclor for treatment of acute urinary tract infections in women.
AUTOR(ES)
Iravani, A
RESUMO
A total of 108 college women with acute urinary tract infections were treated for 10 days with either 500 mg of cefprozil (BMY-28100-03-800) once a day (n = 72) or 250 mg of cefaclor three times a day (n = 36). Clinical and bacterial cure rates at 1 week posttherapy were 94 and 93%, respectively, for the cefprozil group and 94 and 94%, respectively, for the cefaclor group (P, not significant). Both cefprozil and cefaclor were safe and effective.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=245300Documentos Relacionados
- Loracarbef versus cefaclor in the treatment of urinary tract infections in women.
- Direct antimicrobial susceptibility testing for acute urinary tract infections in women.
- Single-dose amoxicillin therapy of acute uncomplicated urinary tract infections in women.
- Prospective comparison of amoxicillin-clavulanic acid and cefaclor in treatment of uncomplicated urinary tract infections.
- Comparative efficacy and safety of nalidixic acid versus trimethoprim/sulfamethoxazole in treatment of acute urinary tract infections in college-age women.
